Outcomes and Risk Factors of Septic Shock in Patients With Infective Endocarditis: A Prospective Cohort Study.

Staphylococcus aureus cardiac surgery infective endocarditis sepsis septic shock

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 10 01 2021
accepted: 23 03 2021
entrez: 30 6 2021
pubmed: 1 7 2021
medline: 1 7 2021
Statut: epublish

Résumé

Little is known about the characteristics and impact of septic shock (SS) on the outcomes of infective endocarditis (IE). We aimed to investigate the characteristics and outcomes of patients with IE presenting with SS and to compare them to those of IE patients with sepsis (Se) and those with neither Se nor SS (no-Se-SS). This is a prospective cohort study of 4864 IE patients from 35 Spanish centers (2008 to 2018). Logistic regression analyses were performed to identify risk factors for SS and mortality. Septic shock and Se presented in 597 (12.3%) and 559 (11.5%) patients, respectively. Patients with SS were younger and presented significantly higher rates of diabetes, chronic renal and liver disease, transplantation, nosocomial acquisition, Septic shock is frequent and entails dismal prognosis. Early identification of patients at risk of developing SS and early assessment for cardiac surgery appear as key factors to improve outcomes.

Sections du résumé

BACKGROUND BACKGROUND
Little is known about the characteristics and impact of septic shock (SS) on the outcomes of infective endocarditis (IE). We aimed to investigate the characteristics and outcomes of patients with IE presenting with SS and to compare them to those of IE patients with sepsis (Se) and those with neither Se nor SS (no-Se-SS).
METHODS METHODS
This is a prospective cohort study of 4864 IE patients from 35 Spanish centers (2008 to 2018). Logistic regression analyses were performed to identify risk factors for SS and mortality.
RESULTS RESULTS
Septic shock and Se presented in 597 (12.3%) and 559 (11.5%) patients, respectively. Patients with SS were younger and presented significantly higher rates of diabetes, chronic renal and liver disease, transplantation, nosocomial acquisition,
CONCLUSIONS CONCLUSIONS
Septic shock is frequent and entails dismal prognosis. Early identification of patients at risk of developing SS and early assessment for cardiac surgery appear as key factors to improve outcomes.

Identifiants

pubmed: 34189153
doi: 10.1093/ofid/ofab119
pii: ofab119
pmc: PMC8232381
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofab119

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Références

Eur Heart J. 2013 Jul;34(26):1999-2006
pubmed: 23060453
JAMA. 2018 Jul 3;320(1):72-83
pubmed: 29971402
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
J Thorac Dis. 2019 Oct;11(10):E182-E191
pubmed: 31737334
Heart. 2014 Apr;100(7):524-7
pubmed: 23990639
N Engl J Med. 2013 Aug 29;369(9):840-51
pubmed: 23984731
N Engl J Med. 2013 Apr 11;368(15):1425-33
pubmed: 23574121
Ann Intensive Care. 2015 Dec;5(1):45
pubmed: 26621197
J Am Coll Cardiol. 2020 Feb 11;75(5):482-494
pubmed: 32029130
Open Forum Infect Dis. 2019 Jul 16;6(9):ofz308
pubmed: 31660397
Eur Heart J. 2014 May;35(18):1195-204
pubmed: 23964033
Ann Thorac Surg. 2012 May;93(5):1469-76
pubmed: 22342063
Europace. 2020 Jul 1;22(7):1062-1070
pubmed: 32390046
Clin Infect Dis. 2000 Apr;30(4):633-8
pubmed: 10770721
Lancet. 2012 Mar 10;379(9819):965-975
pubmed: 22317840
Intensive Care Med. 2003 Apr;29(4):530-8
pubmed: 12664219
Lancet. 2020 Jan 18;395(10219):200-211
pubmed: 31954465
Shock. 2018 May;49(5):536-542
pubmed: 28991051
Ann Cardiothorac Surg. 2019 Nov;8(6):621-629
pubmed: 31832352
Crit Care Med. 2017 Mar;45(3):486-552
pubmed: 28098591

Auteurs

Juan M Pericàs (JM)

Infectious Diseases Department, Hospital Clinic, Barcelona, Spain.
Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
University of Barcelona, Barcelona, Spain.

Marta Hernández-Meneses (M)

Infectious Diseases Department, Hospital Clinic, Barcelona, Spain.
Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
University of Barcelona, Barcelona, Spain.

Patricia Muñoz (P)

Clinical Microbiology and Infectious Diseases Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
CIBER Enfermedades Respiratorias-CIBERES (CB06/06/0058), Instituto de Salud Carlos III, Madrid, Spain.
Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.

Ana Álvarez-Uría (A)

Clinical Microbiology and Infectious Diseases Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
CIBER Enfermedades Respiratorias-CIBERES (CB06/06/0058), Instituto de Salud Carlos III, Madrid, Spain.
Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.

Blanca Pinilla-Llorente (B)

Internal Medicine Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Arístides de Alarcón (A)

Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine Infectious Diseases Research Group, Virgen del Rocío and Virgen Macarena University Hospitals, Seville, Spain.
Institute of Biomedicine of Seville (IBIS), University of Seville/CSIC, Seville, Spain.

Karlos Reviejo (K)

Policlínica Gipuzkoa, Grupo Quirón, San Sebastián, Spain.

M Carmen Fariñas (MC)

Infectious Diseases Unit. Hospital Universitario Marqués de Valdecilla, Santander, Spain.
University of Cantabria, Santander, Spain.

Carlos Falces (C)

Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
University of Barcelona, Barcelona, Spain.
Cardiology Department, Hospital Clinic, Barcelona, Spain.

Josune Goikoetxea-Agirre (J)

Infectious Diseases Department, Hospital Universitario de Cruces, Bilbao, Spain.

Juan Gálvez-Acebal (J)

Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine Infectious Diseases Research Group, Virgen del Rocío and Virgen Macarena University Hospitals, Seville, Spain.
Institute of Biomedicine of Seville (IBIS), University of Seville/CSIC, Seville, Spain.

Carmen Hidalgo-Tenorio (C)

Infectious Diseases Department, Hospital Universitario Virgen de las Nieves, Granada, Spain.

Eloy Gómez-Nebreda (E)

Infectious Diseases Unit, Internal Medicine Department, Hospital General de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain.

Jose M Miro (JM)

Infectious Diseases Department, Hospital Clinic, Barcelona, Spain.

Classifications MeSH